Find news and infos about LTS

Dr. Reddy’s re-launches generic of Buprenorphine and Naloxone Sublingual Film

DATE

February 21, 2019

CATEGORY
FOLLOW US

LTS congratulates its business partner Dr. Reddy’s Laboratories Ltd. on the re-launch of its Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version of Suboxone® (buprenorphine and naloxone) sublingual film, in the United States market.

Buprenorphine and Naloxone Sublingual Film is a prescription medicine indicated for treatment of opioid use disorder.

LTS manufactures the Buprenorphine and Naloxone Sublingual Film for Dr. Reddy’s in its production site in West Caldwell, New Jersey, USA.

More about this topic